Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06565364
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-07
Brief Title:
Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary aim of this study was to describe the prevalence and time course of the occurrence of protamineheparin antibodies in patients undergoing cardiac surgery on cardiopulmonary bypass
The second aim was to identify triggers of immunization
The third aim of this study was to evaluate a potential clinical impact of protamineheparin antibodies and their platelet-activating properties leading to thromboembolism and other adverse outcomes
The second aim was to identify triggers of immunization
The third aim of this study was to evaluate a potential clinical impact of protamineheparin antibodies and their platelet-activating properties leading to thromboembolism and other adverse outcomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None